Abstract
For decades, it has been recognized that cancer cells display a unique metabolism; specifically, cancer cells have been shown to preferentially utilize glycolysis instead of mitochondrial respiration. This phenomenon is commonly known as the “Warburg effect” after Otto Warburg who first made this observation in 1927. The discovery of the Warburg effect has lead to new methods of detection and differentiation of cancerous tissue and normal tissue. More recently, alterations in cancer metabolism have been researched as a possible target for chemotherapeutic intervention in a number of cancers. The push to understand the metabolism of cancer cells has been particularly acute in breast cancer cells, where multiple novel metabolic mechanisms have recently been described and characterized. However, despite this recent progress, the completion of additional studies on the cellular metabolism of breast cancer cells is necessary before drugs that target cancer cell metabolism could be available to disease-afflicted women. Here, we review recent discoveries in breast cancer cell metabolism as well as current logical drug targets that could be used to alter cell metabolism to promote the selective elimination of breast cancer cells.
Keywords: Breast cancer, cell metabolism, cell death, glucose metabolism, hypoxia, Warburg effect, autophagy, cancer metabolism
Current Drug Targets
Title: Keeping A Breast of Recent Developments in Cancer Metabolism
Volume: 11 Issue: 9
Author(s): Calli A. Davison and Zachary T. Schafer
Affiliation:
Keywords: Breast cancer, cell metabolism, cell death, glucose metabolism, hypoxia, Warburg effect, autophagy, cancer metabolism
Abstract: For decades, it has been recognized that cancer cells display a unique metabolism; specifically, cancer cells have been shown to preferentially utilize glycolysis instead of mitochondrial respiration. This phenomenon is commonly known as the “Warburg effect” after Otto Warburg who first made this observation in 1927. The discovery of the Warburg effect has lead to new methods of detection and differentiation of cancerous tissue and normal tissue. More recently, alterations in cancer metabolism have been researched as a possible target for chemotherapeutic intervention in a number of cancers. The push to understand the metabolism of cancer cells has been particularly acute in breast cancer cells, where multiple novel metabolic mechanisms have recently been described and characterized. However, despite this recent progress, the completion of additional studies on the cellular metabolism of breast cancer cells is necessary before drugs that target cancer cell metabolism could be available to disease-afflicted women. Here, we review recent discoveries in breast cancer cell metabolism as well as current logical drug targets that could be used to alter cell metabolism to promote the selective elimination of breast cancer cells.
Export Options
About this article
Cite this article as:
A. Davison Calli and T. Schafer Zachary, Keeping A Breast of Recent Developments in Cancer Metabolism, Current Drug Targets 2010; 11 (9) . https://dx.doi.org/10.2174/138945010792006861
DOI https://dx.doi.org/10.2174/138945010792006861 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomic Studies Using Microarrays
Current Proteomics Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets The Relationship between Pre-miR-3131 3-bp Insertion/Deletion Polymorphism and Susceptibility and Clinicopathological Characteristics of Patients with Breast Cancer
MicroRNA MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment
MicroRNA Hesperidin Potentiates Ghrelin Signaling
Recent Patents on Food, Nutrition & Agriculture Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical Applications
Current Stem Cell Research & Therapy Ultrasound Image Based Tumor Classification via Deep Polynomial Network and Multiple Kernel Learning
Current Medical Imaging A Novel Strategy for Preparing Glycopeptide Molecular Probe Using Fluorous Technology
Protein & Peptide Letters In Silico Design, Synthesis and Bioactivity of N-(2, 4-Dinitrophenyl)-3-oxo- 3-phenyl-N-(aryl) Phenyl Propanamide Derivatives as Breast Cancer Inhibitors
Current Computer-Aided Drug Design Profiling of Autophagy-Associated microRNAs in the Osteosarcoma Cell Line of U2OS
Anti-Cancer Agents in Medicinal Chemistry Structural Requirements of Heparin and Related Molecules to Exert a Multitude of Anti-Inflammatory Activities
Mini-Reviews in Medicinal Chemistry Mn-SOD and Chronic Inflammation of Gastric Mucosa
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Spectroscopic Characterization of a Pyridine Alkaloid from an Endophytic Strain of the Fusarium incarnatum-equiseti Species Complex
Current Bioactive Compounds Use of Transgenic Mice as Models for Prostate Cancer Chemoprevention
Current Molecular Medicine A Rare Case Report of Inguinal Herniation with Urinary Bladder as its Content
New Emirates Medical Journal Cardioprotective effects of Aronia melanocarpa anthocynanins. From laboratory experiments to clinical practice.
Current Pharmaceutical Design Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity
Current Genomics SPECT-CT and PET-CT in Oncology - An Overview
Current Medical Imaging